Genomics In Cancer Care Market 2030: The Intersection of Genomics and Immunotherapy

The global genomics in cancer care market size is expected to reach USD 50.97 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 16.0% from 2024 to 2030. Increasing prevalence of cancer coupled with adoption of next generation sequencing for the diagnosis & treatment is expected to fuel the market with future growth opportunities. Increasing incidences of cancer triggers the demand for cost effective and accurate diagnostics in coming years.

In addition, increasing demand for personalized medicines in molecular characterization of cancer to identify therapeutic targets is the factor attributing towards the market growth. Similarly, factors such as cost reduction in genome sequencing, growing healthcare expenditure levels and development of effective diagnostics & therapeutic procedures for cancer are responsible for the potential growth of genomics in cancer care.

Gather more insights about the market drivers, restrains and growth of the Genomics In Cancer Care Market

Genomics In Cancer Care Market Report Highlights

• Instrument segment dominated the overall market in terms of revenue share as of 2023 and accounted for 54.8% of market owing to high cost associated with it. Whereas, consumables are most widely used product segment in genome testing as they are indispensible component and frequently required to perform the test.
• Demand for services such as next generation sequencing, PCR and other such as cancer risk management & genetic testing are expected to grow over the forecast period due to increasing outsourcing activities to perform genome analysis. High cost of performing genetic tests and growing awareness pertaining to associated benefits with the use of these technologies are high impact rendering drivers for this segment.
• Drug discovery and development segment is expected to show lucrative CAGR of 18.5% during the forecast period owing to increasing demand for effective treatment for cancer and growing investment in biomedicines by manufacturers for the development of novel products. 

Browse more reports published by Grand View Research.

• Immunoprotein Diagnostic Testing Market Size, Share & Trends Analysis Report By Test, By Technology, By Application, By Distribution Channel, By End Use, By Region, And Segment Forecasts, 2024 – 2030
• DNA And Gene Cloning Services Market Size, Share & Trends Analysis Report By Service (Gene Synthesis, Custom Cloning), By Application (DNA Sequencing, Mutagenesis), By End Use, By Region, And Segment Forecasts, 2024 – 2030

List of Key Players of Genomics In Cancer Care Market

• Agilent Technologies, Inc.
• F. Hoffmann-La Roche Ltd
• Beckman Coulter, Inc.
• Illumina Inc.
• Abbott
• Cancer Genetic Inc.
• Bio-Rad Laboratories, Inc.
• PacBio
• GE Healthcare
• Quest Diagnostics Incorporated
• PerkinElmer
• Luminex 

About Grand View Research

Grand View Research is a full-time market research and consulting company registered in San Francisco, California. The company fully offers market reports, both customized and syndicates, based on intense data analysis. It also offers consulting services to business communities and academic institutions and helps them understand the global and business scenario to a significant extent. The company operates across multitude of domains such as Chemicals, Materials, Food and Beverages, Consumer Goods, Healthcare, and Information Technology to offer consulting services.

Explore Horizon, the world’s most expansive market research database